Ferronova

Ferronova

Private
AdelaideHealthcare & Life Scienceshttps://ferronova.com.au

Last Round

Series A

Extension

Dec 17, 2025

Total Funding Raised

$22.7M

Momentum Score

25 /100

Company Overview

Ferronova is a medical technology company developing a nanoparticle-based imaging solution to help surgeons more accurately identify and remove cancerous tissue during operations.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Medical Imaging, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

sentinel lymph node biopsySLNBnanoparticle tracerFerroTracelymph node mappingSPIONssuper-paramagnetic iron-oxide nanoparticlessurgical oncologyhandheld magnetometerFerroMagcancer stagingmagnetic tracermedtechsurgical guidancenon-radioactive tracercancer surgerymedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ferronova Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ferronova Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionDec 17, 2025
Series ADec 17, 2025
Series A ExtensionJan 22, 2023
GrantJan 22, 2023
Series AMay 26, 2020

Ferronova Investors

Notable investors and investment history

InvestorRounds
Powerhouse VenturesSeed
UniSuper ManagementSeries A
ArtesianSeries A
UniseedSeries A Extension, Series A
South Australian Venture Capital FundSeries A Extension, Series A
Stoic Venture CapitalSeries A
UniSA VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Aki Smith appointed to scientific advisory board.

  • Jan 1, 2026

    Enrolled 92 patients across multiple clinical trials.

Ferronova Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ferronova Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ferronova's valuation, stock price, and market status.

Firmographic Details

HeadquartersAdelaide
Employee Range17
Year Founded2016
Last FundingDec 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.